1 Global Blood Testing Market Insight Analysis
The global blood testing market size is expected to reach USD 48,076 million in 2025, with a CAGR of 3.5% from 2025 to 2033.
Perform blood tests to determine a person’s health. Blood tests are often used in the field of healthcare to determine organ function, physiological and biochemical status, disease transmission, and drug effectiveness. The increasing importance and demand for blood testing is expected to drive the growth of the global blood testing market in the next few years.
Figure Global Blood Testing Market Size (M USD) and CAGR (2025-2033)
2 Blood Testing Market Growth Drivers and Restraints
Growth in medical demand: With the aging of the global population and the rising incidence of chronic diseases, the demand for blood testing continues to increase. Taking diabetes as an example, the number of patients worldwide is increasing, and blood glucose testing is an important means of diagnosing and treating diabetes, which has led to the continuous expansion of the glucose testing market. In addition, the improvement of people’s health awareness has also increased the demand for preventive physical examinations. As a basic examination item, the market demand for blood testing has increased accordingly.
Technological progress: Technological innovation has brought new opportunities to the blood testing market. For example, the development of microfluidics has made home blood testing equipment more convenient and accurate, which has promoted the growth of the home testing market. At the same time, the application of advanced technologies such as molecular diagnosis and genetic testing can detect diseases more accurately, meet clinical needs, and further expand the scope of application of blood testing.
Policy support: The increased attention and investment of governments in the medical and health field has provided a favorable policy environment for the development of the blood testing market. The government has increased its investment in medical infrastructure construction and improved the testing capabilities of hospitals and diagnostic laboratories. Some countries have also introduced policies to encourage the research and development and application of innovative medical technologies, which has promoted the development of the blood testing industry.
Epidemic-related impact: Although the COVID-19 pandemic has increased the demand for blood testing to a certain extent, it has also brought many adverse effects. The lockdown measures caused by the epidemic have reduced the number of blood donations and affected the blood testing-related business. For example, during the epidemic in the United States, the amount of blood donations decreased, and some hospitals were short of blood supply, which in turn affected the development of related testing work. At the same time, the epidemic caused an economic recession, people’s consumption capacity declined, and they were more cautious about spending on non-essential medical tests, which to a certain extent suppressed market growth.
Intensified industry competition: The blood testing market is highly competitive, and many companies have poured in, resulting in a dispersed market share. In order to compete for the market, various companies have continuously lowered prices and compressed profit margins, affecting the overall profitability of the industry. Some small companies may find it difficult to survive in the competition due to insufficient funds, technology, etc., which in turn affects the stable development of the industry.
Inconsistent technical standards: At present, the technical standards of the blood testing industry have not yet been fully unified, and there are differences in the testing products and methods of different companies, which poses challenges to the accuracy and comparability of the test results. For example, different brands of cholesterol testing reagents may have different detection principles and reference ranges, resulting in differences in test results, affecting the accuracy of clinical diagnosis and limiting the further development of the market.
3 Technological Innovations in the Blood Testing Market
Diversified development of detection technology: In the field of blood testing, a variety of innovative technologies continue to emerge. In addition to the continuous improvement of traditional biochemical detection technology, molecular diagnostic technologies such as polymerase chain reaction (PCR) and fluorescence in situ hybridization (FISH) have been widely used in pathogen detection and gene analysis. Immunoassay technology has also been continuously upgraded, and technologies with higher sensitivity and specificity such as chemiluminescent immunoassay and electrochemiluminescent immunoassay have gradually become mainstream. In addition, the development of microfluidic chip technology has enabled blood testing to be miniaturized, integrated and automated, and multiple detection items can be completed on a chip, greatly improving detection efficiency and portability.
Breakthrough in home detection technology: With the advancement of technology, home blood testing technology has made important breakthroughs. For example, home blood sugar and blood lipid detection equipment based on biosensor technology is simple to operate, fast to detect, and the accuracy is constantly improving. Some companies have also launched home blood test kits that can detect multiple indicators. Through fingertip blood sampling or saliva testing, multiple health indicators can be tested at home, providing consumers with a more convenient way to monitor their health.
Giants layout to improve the industrial chain: Large companies continue to improve their own industrial chain layout through mergers and acquisitions. For example, Danaher has acquired several companies that focus on the research and development and production of blood testing equipment and reagents, integrated resources, and achieved full industry chain coverage from testing instruments to supporting reagents, enhancing the competitiveness of enterprises in the market. This kind of merger and acquisition not only helps enterprises reduce costs and improve production efficiency, but also enhances the research and development capabilities of enterprises and accelerates the launch of new products.
Promote industry integration and centralization: Corporate mergers and acquisitions have promoted the integration of the blood testing industry, and the market concentration has gradually increased. Some small companies have been acquired by large companies in competition due to their disadvantages in technology, capital, etc. For example, in the global market, a few large companies such as Roche (F. Hoffmann-La Roche AG) and Abbott Laboratories have continuously expanded their market share through mergers and acquisitions with strong R&D strength and extensive market channels, and the industry structure has gradually developed towards centralization. This helps to optimize the allocation of industry resources and improve the overall operational efficiency and product quality of the industry.
4 Global Blood Testing Market Size by Type
In 2025, glucose testing is projected to be the largest segment within the blood testing market, reflecting the significant impact of diabetes on global health. The revenue from glucose tests is expected to reach $16,118 million, accounting for a substantial portion of the total market.
Cholesterol testing, with a revenue of $6,291 million, is another significant segment, driven by the need for cardiovascular disease prevention and management. Vitamin D testing, though smaller in scale, is also important for public health, with a projected revenue of $737 million.
TSH testing, with a revenue of $2,511 million, is crucial for thyroid disorder management, which affects a considerable portion of the population. Testosterone testing, while not as prevalent, still holds a place in the market with a revenue of $343 million, particularly important for reproductive health assessments.
Table Global Blood Testing Market Size by Type in 2025
Type | Market Size (M USD) 2025 |
|---|---|
Testosterone | 343 |
Cholesterol | 6291 |
Vitamin D | 737 |
Thyroid-stimulating Hormone | 2511 |
Glucose | 16118 |
Others | 22075 |
5 Global Blood Testing Market Size by Application
In 2025, hospitals are projected to be the largest segment within the blood testing market, reflecting the central role of hospitals in providing comprehensive healthcare services. The revenue from hospital-based blood testing is expected to reach $26,211 million, accounting for a significant portion of the total market.
Diagnostic laboratories follow closely with a revenue of $10,529 million, indicating the importance of specialized testing services in healthcare. These laboratories offer a range of tests that are essential for accurate diagnosis and effective treatment planning.
Home tests, with a revenue of $5,549 million, represent a growing segment of the market. The convenience and accessibility of home testing kits are driving their popularity, especially among consumers who prefer to manage their health independently.
Table Global Blood Testing Market Size by Application in 2025
Application | Market Size (M USD) 2025 |
|---|---|
Home Tests | 5549 |
Diagnostic Laboratories | 10529 |
Hospitals | 26211 |
Others | 5788 |
6 Global Blood Testing Market Size by Region
North America held a significant position in the global blood testing market, with a market revenue of 16,441 million USD in 2025. This region has a well – established healthcare infrastructure, advanced medical technology, and a high level of awareness regarding preventive healthcare. The United States, in particular, is a major contributor to this revenue. It has a large number of leading medical research institutions and pharmaceutical companies, which drive continuous innovation in blood testing technologies.
For example, many cutting – edge diagnostic techniques, such as advanced genetic blood tests, were first developed and commercialized in North America. Additionally, the region has a relatively high per – capita healthcare expenditure, enabling patients to afford a wide range of blood testing services. The presence of a mature insurance system also supports the demand for blood testing, as it covers a significant portion of the costs for patients.
Europe’s blood testing market revenue reached 13,391 million USD in 2025. The region has a long – standing tradition of high – quality healthcare services. European countries have made substantial investments in medical research and development, resulting in a diverse portfolio of blood testing products and services. Germany, France, and the United Kingdom are among the key players in the European blood testing market. Stringent regulatory frameworks in Europe ensure the safety and efficacy of blood testing products, which in turn boosts consumer confidence.
Moreover, the aging population in many European countries has led to an increased demand for blood tests related to chronic diseases such as diabetes, cardiovascular diseases, and cancer. However, challenges such as budget constraints in some healthcare systems and differences in healthcare policies among member states can sometimes pose obstacles to the seamless growth of the blood testing market.
The Asia Pacific region’s blood testing market revenue was 14,331 million USD in 2025. This region has been experiencing rapid growth in recent years. Driven by factors such as a large and growing population, improving economic conditions, and increasing healthcare awareness, the demand for blood testing services has been on the rise. China and India, with their vast populations, are major growth engines. In China, continuous investment in healthcare infrastructure, along with the development of domestic medical technology companies, has led to a significant expansion of the blood testing market.
The increasing prevalence of non – communicable diseases like hypertension and diabetes in the region has also spurred the demand for related blood tests. Additionally, Japan and South Korea, with their advanced medical technology and high – income levels, contribute to the market’s growth through their demand for high – end blood testing products and services. However, the region still faces challenges such as uneven healthcare development across different countries and areas, and the need to further improve access to advanced blood testing technologies in some less – developed regions.
Figure Global Blood Testing Market Size (M USD) by Region in 2025
7 Global Blood Testing Market Analysis by Major Players
F. Hoffmann-La Roche AG
Company Profile: F. Hoffmann-La Roche AG, headquartered in Basel, Switzerland, is a global leader in pharmaceuticals and diagnostics. Established in 1896, Roche has a rich history of medical innovation and is committed to improving patient lives.
Business Overview: Roche operates worldwide, offering a broad range of pharmaceutical products and diagnostic solutions. Their diagnostics division, Roche Diagnostics, provides comprehensive solutions across molecular diagnostics, clinical chemistry, immunoassays, and more. Roche is dedicated to advancing healthcare by delivering state-of-the-art diagnostic tools that enable precise and personalized patient care.
Product Offered: Roche’s product portfolio in blood testing includes a variety of diagnostic tests and equipment. Notably, they offer donor screening solutions to ensure the safety of blood transfusions and plasma-derived therapeutics. Their tests cover a wide array of conditions, from infectious diseases to genetic disorders, and their instruments are designed for high performance and reliability. Roche’s commitment to innovation is evident in their next-generation sequencing and laboratory automation solutions, which streamline diagnostic processes and enhance accuracy.
Abbott Laboratories
Company Profile: Abbott Laboratories, an American multinational medical device and healthcare company, is headquartered in Abbott Park, Illinois, USA. Founded in 1888, Abbott has a long-standing reputation for developing breakthrough products in diagnostics, medical equipment, nutrition, and branded generic drugs.
Business Overview: Abbott Laboratories serves customers worldwide, focusing on improving health outcomes through innovative solutions. Their diagnostics business is a significant part of their operations, offering a wide range of tests and analyzers for various healthcare settings, from point-of-care to reference laboratories.
Product Offered: Abbott’s blood testing products include the Cholestech LDX™ Analyzer, designed for accurate and accessible lipid, cholesterol, and glucose testing. Their products are known for fast and reliable results, meeting the lipid performance goals of the National Cholesterol Education Program (NCEP). Abbott also offers a range of other diagnostic tests and equipment, including blood gas and chemistry analyzers, immunoassay systems, and molecular diagnostics solutions. Their focus on precision and user-friendliness makes Abbott a key player in the blood testing market.
Danaher Corporation
Company Profile: Danaher Corporation, headquartered in Washington, D.C., is a global diversified industrial manufacturer and a leader in designing, manufacturing, and marketing professional, medical, industrial, and commercial products and services.
Business Overview: Established in 1969, Danaher operates in multiple sectors, including life sciences, diagnostics, dental, environmental, and applied solutions. Their business model is built on a decentralized structure, allowing each of their operating companies to be a leader in its respective market.
Product Offered: In the blood testing market, Danaher offers a range of products under its RadiationMeter brand, which specializes in blood gas analysis, percutaneous monitoring, and immunoassays for heart, coagulation, infection, and pregnancy markers. Their equipment is used globally, with a focus on providing fast and accurate diagnostics to support immediate healthcare decisions. Danaher’s commitment to quality and innovation has made their products a staple in emergency care environments and routine diagnostics.